Duke Rohlen is the founder of Ablacon. Ablacon has raised $54M in total funding. Latest round: Series A. Backed by Ajax Health.
Duke Rohlen is the CEO of Ablacon, a Wheat Ridge, Colorado-based company developing an AI-enabled mapping system for treating atrial fibrillation (AFib). He joined Ablacon as CEO in 2019 after Ajax Health led the company's initial Series A financing. Rohlen has over two decades of experience in medical devices.
Full founder directory · Investor directory · Company funding database · Fundraising library